Related references
Note: Only part of the references are listed.Life-expectancy of patients enrolled in phase 1 clinical trials: A systematic review of published prognostic models
Anne Ploquin et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors
David Olmos et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Baseline Circulating Tumor Cell Counts Significantly Enhance a Prognostic Score for Patients Participating in Phase I Oncology Trials
David Olmos et al.
CLINICAL CANCER RESEARCH (2011)
Tumour growth rates and RECIST criteria in early drug development
Carlos Gomez-Roca et al.
EUROPEAN JOURNAL OF CANCER (2011)
Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics
Nicolas Penel et al.
INVESTIGATIONAL NEW DRUGS (2010)
Survival of Patients in a Phase 1 Clinic The M. D. Anderson Cancer Center Experience
Jennifer Wheler et al.
CANCER (2009)
Sufficient Life Expectancy: An Amazing Inclusion Criterion in Cancer Phase II-III Trials
Nicolas Penel et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials
Hendrik-Tobias Arkenau et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience
H-T Arkenau et al.
BRITISH JOURNAL OF CANCER (2008)
90-Days mortality rate in patients treated within the context of a phase-I trial: How should we identify patients who should not go on trial?
Hendrik-Tobias Arkenau et al.
EUROPEAN JOURNAL OF CANCER (2008)
Comparing performances of logistic regression, classification and regression tree, and neural networks for predicting coronary artery disease
Imran Kurt et al.
EXPERT SYSTEMS WITH APPLICATIONS (2008)
Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy
A. Italiano et al.
ANNALS OF ONCOLOGY (2008)
Prognostic factors among cancer patients with good performance status screened for phase I trials
Nicolas Penel et al.
INVESTIGATIONAL NEW DRUGS (2008)
A comparison of regression trees, logistic regression, generalized additive models, and multivariate adaptive regression splines for predicting AMI mortality
Peter C. Austin
STATISTICS IN MEDICINE (2007)
Predicting outcomes of neonates diagnosed with hypoxemic-ischemic encephalopathy
Namasivayam Ambalavanan et al.
PEDIATRICS (2006)
Predicting employment outcomes of rehabilitation clients with orthopedic disabilities: A CHAID analysis
F Chan et al.
DISABILITY AND REHABILITATION (2006)
Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents
C Han et al.
BRITISH JOURNAL OF CANCER (2003)
External validation is necessary in, prediction research: A clinical example
SE Bleeker et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
M Ando et al.
BRITISH JOURNAL OF CANCER (2001)
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials
T Bachelot et al.
ANNALS OF ONCOLOGY (2000)
Recurrent immunoglubulin gene translocations identify distinct molecular subtypes of myeloma
M Chesi et al.
ANNALS OF ONCOLOGY (2000)
Share Paper
